J9228 Ipilimumab injection
Also known as: ipilimumab, Yervoy
Intravenous injection of ipilimumab, a monoclonal antibody targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immune checkpoint.
In Plain Language
immune checkpoint inhibitor; cancer-fighting immune therapy
Clinical Context
Used for melanoma and other advanced cancers by blocking CTLA-4 checkpoint to enhance T-cell immune response.
RVU Information
CPT J9228 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9228?
CPT J9228 (Ipilimumab injection) is a J Codes (Drugs) code. Intravenous injection of ipilimumab, a monoclonal antibody targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immune checkpoint.
How is J9228 administered?
CPT J9228 is administered by a healthcare provider, typically via injection or infusion. Used for melanoma and other advanced cancers by blocking CTLA-4 checkpoint to enhance T-cell immune response. It is used by Oncology, Immunotherapy.
When is CPT J9228 used?
Used for melanoma and other advanced cancers by blocking CTLA-4 checkpoint to enhance T-cell immune response.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.